Two Sigma Investments, LP Clene Inc. Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.95 - $1.62 $57,788 - $98,544
60,830 Added 508.19%
72,800 $82,000
Q4 2022

Feb 14, 2023
SELL
$0.92 - $1.11 $19,714 - $23,786
-21,429 Reduced 64.16%
11,970 $11,000
Q3 2022

Nov 14, 2022
BUY
$0.33 - $4.83 $11,021 - $161,317
33,399 New
33,399 $94,000

Others Institutions Holding CLNN

# of Institutions
54
Shares Held
7.44M
Call Options Held
48.1K
Put Options Held
160K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $21M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email